Skip to main content

Table 2 Secondary outcome measures and process evaluation

From: Collaborative approach to Optimise MEdication use for Older people in Nursing homes (COME-ON): study protocol of a cluster controlled trial

 

Measure

Secondary outcome measures

 Appropriateness of prescribing, individual components

-Prevalence of PIM and PPO per criterion

 Medication use

-Number of medications per NHR

-Classes of medications used (ATC level 2 and 3)

 Clinical outcomes

-Death

-Hospital admissions

-Visits to an emergency department

-Visits to the GP and to specialist physicians

 Outcomes of case conferences

-Type of identified DRPs

-Type of planned interventions

-Mean/median number of DRPs identified per NHR

-Proportion of interventions implemented at the next case conference

 Cost

-Cost of medication

-Cost of healthcare use (hospital admissions, visits to the emergency department, GP visits, consultation with specialists)

-Cost of intervention

Process evaluation

 

 Training

-Dose (number of module per profession,…)

-Reach (rate of participation,…)

-Experience with intervention (satisfaction survey)

 Local concertation

-Fidelity (percentage of NHs that organised 2 local concertations,…)

-Dose (number of local concertations per NH)

-Reach (number of participating GPs who attended local concertation,…)

-Experience with intervention (semi-structured interviews and focus groups)

 Interdisciplinary case conferences

-Fidelity (percentage of NHRs for which 3 interdisciplinary case conferences were conducted,…)

-Dose (median number of case conferences per NHR,…)

-Reach (who attended case conferences,…)

-Experience with intervention (semi-structured interviews and focus groups)

 Context of the NH

-Characteristics of NHs and HCPs

-Context in which the intervention is being implemented (semi-structured interviews)

  1. PIM potentially inappropriate medication, PPO potentially prescribing omission, NHR(s) nursing home resident(s), GP general practitioner, NH(s) nursing home(s), DRP(s) drug-related problem(s), HCPs health-care professionals